Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Targeting the pro-metastatic function of cancer-associated fibroblasts in breast cancer: the promise of inhibiting the MNK/4E signaling axis
FY 2020-21
Summary
In Canada, breast cancer alone accounts for approximately 13% of all deaths in women due to cancer. Up to 90% of these deaths do not occur due to the initial tumor, but from the secondary growths that travel from the primary site to distant organs (process of metastasis). One strategy employed by cancer is the dysregulation of normal protein production, allowing it to more easily adapt and gain the ability to spread throughout the body. Knowledge of this dysregulation process is limited to what happens within cancer cells only. However, a tumor is composed of cancer cells as well as non-cancerous stromal cells. It is known that cancer re-educates these surrounding stromal cells, resulting in a change of behaviour that is supportive of tumor growth and progression. My project focuses on these stromal cells and the role that protein production dysregulation in them plays in assisting cancer progression. To research this, I will focus on a molecule called eIF4E (an integral piece of the protein production machinery) in a re-educated stromal cell called cancer associated fibroblasts (CAFs). CAFs facilitate tumor growth and invasion by suppressing the immune system and redesigning the surrounding tissue, but eIF4E's contribution is unknown. A combination of cell culture experiments and mouse breast cancer models will be employed to ascertain its contribution, with a focus on whether eIF4E inhibition is effective in blocking breast cancer metastasis. The data gathered through this study is expected to help shape the pre-clinical therapeutic models being designed to better treat patients with breast cancer. For example, it will directly impact our recently funded Stand Up 2 Cancer trial, testing inhibitors of faulty protein production in women with metastatic breast cancer.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449583
Name
Smith-Voudouris Julian
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting the pro-metastatic function of cancer-associated fibroblasts in breast cancer: the promise of inhibiting the MNK/4E signaling axis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Cancer; Eif4e Phosphorylation; Fibroblast; Metastasis; Mnk1/2; Proteomics; Translational Regulation; Tumor Microenvironment
Abstract
In Canada, breast cancer alone accounts for approximately 13% of all deaths in women due to cancer. Up to 90% of these deaths do not occur due to the initial tumor, but from the secondary growths that travel from the primary site to distant organs (process of metastasis). One strategy employed by cancer is the dysregulation of normal protein production, allowing it to more easily adapt and gain the ability to spread throughout the body. Knowledge of this dysregulation process is limited to what happens within cancer cells only. However, a tumor is composed of cancer cells as well as non-cancerous stromal cells. It is known that cancer re-educates these surrounding stromal cells, resulting in a change of behaviour that is supportive of tumor growth and progression. My project focuses on these stromal cells and the role that protein production dysregulation in them plays in assisting cancer progression. To research this, I will focus on a molecule called eIF4E (an integral piece of the protein production machinery) in a re-educated stromal cell called cancer associated fibroblasts (CAFs). CAFs facilitate tumor growth and invasion by suppressing the immune system and redesigning the surrounding tissue, but eIF4E's contribution is unknown. A combination of cell culture experiments and mouse breast cancer models will be employed to ascertain its contribution, with a focus on whether eIF4E inhibition is effective in blocking breast cancer metastasis. The data gathered through this study is expected to help shape the pre-clinical therapeutic models being designed to better treat patients with breast cancer. For example, it will directly impact our recently funded Stand Up 2 Cancer trial, testing inhibitors of faulty protein production in women with metastatic breast cancer.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Smith-Voudouris, Julian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~